Inclusion Criteria  Female adult aged 18 and older; Clinical diagnosis of early-stage (Stage I, II, or IIIa), hormone-receptor-positive breast cancer; Completion of surgery, and/or chemotherapy and/or radiotherapy; Currently taking the third generation of AIs (anastrozole, letrozole, or exemestane) for at least 1 month; Based on their self-reports of moderate symptoms of joint pain and fatigue or sleep disturbance; Willing to comply with the intervention protocol, and Being able to communicate in Chinese .  Exclusion Criteria:  Previous receipt of acupuncture and acupressure within the past six months; Currently receiving medications (unchanged for 3 month), physical therapy and other complementary and alternative medicines for the treatment of joint pain, fatigue and sleep disturbance; Prior joint surgery or fracture during the past six months; Mentally incapable of participating in the study (Hong Kong version of Montreal Cognitive Assessment score<22);and Inability to perform self-care (Karnofsky Performance Scale score<70).